$BKV

BKV Financials: Revenue Breakdown, Margins & Competitor Comparison

This article provides an overview of BKV Corp's financial performance, focusing on its profitability and market position. Key metrics include a gross margin of 100%, an operating margin of 12.32%, and a net margin of 27.15%, alongside a Return on Equity (ROE) of 9.62%. The company, with a market capitalization of $3.02 billion, is also benchmarked against competitors like SOC and MNR, highlighting its leading position and efficiency in the sector.

Original reporting
Published Apr 5, 2026, 12:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 5, 2026, 1:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$BKV
Bullish
high confidence
Mentioned
$BKV · $SOC · $MNR
alphai data visualization · based on Intellectia AI
Decision brief

The 30-second read

$BKVBullishMed
01

Why it matters

Positive financial health may lead to stock appreciation, but valuation levels and macro factors should be considered.

02

Market read

The company's strong financials and sector position suggest potential for stock appreciation, making it relevant for traders seeking growth opportunities.

03

What to watch

Potential risks include market saturation, regulatory changes, or macroeconomic downturns affecting profitability.

Timing: short to medium term (next 1-3 months)

Background

BKV Corp has shown consistent profitability and efficiency, outperforming some competitors in key financial metrics.

Company-level read

Ticker impact

$BKVBullishHigh confidence
Context

Primary focus of the article, providing detailed financial metrics and competitive positioning.

Expected impact

Moderate upward price movement expected in the short to medium term.

Evidence & confidence

The company's high gross margin (100%), positive net margin (27.15%), and robust ROE (9.62%) suggest efficient operations and profitability. Benchmarking against competitors like SOC and MNR further supports its leading sector position.

$SOCNeutralLow confidence
Context

Benchmark competitor mentioned for comparison; minimal direct impact unless sector-wide changes occur.

Expected impact

Limited impact on SOC's stock price based on this article.

Evidence & confidence

The article's focus is on BKV, with only comparative mention of SOC, thus limited relevance for trading decisions regarding SOC.

$MNRNeutralLow confidence
Context

Benchmark competitor; minimal impact unless sector dynamics shift significantly.

Expected impact

No immediate impact expected on MNR.

Evidence & confidence

Lack of specific data about MNR limits its relevance for immediate trading actions.

Market effects

The article suggests sector-wide efficiency and profitability improvements, potentially boosting sector sentiment.

Limited regional impact; data is company-specific.

Moderate, as BKV's performance could influence sector indices and investor sentiment globally.

Counterpoint

High margins may not be sustainable if market conditions change or if competitive pressures increase.

Key entities

  • BKV Corp

    A leading company in its sector with strong financial metrics.

  • SOC

    Benchmark competitor mentioned for comparison.

  • MNR

    Another benchmark competitor for sector comparison.

Related articles

$BKVMedAI 8/10

BKV (BKV) Q2 2026 Earnings Call Transcript

BKV Corporation reported Q2 2026 adjusted EBITDAX of $142 million and adjusted net income of $51 million, and increased full-year upstream production guidance to a midpoint of 950 MMcf/d. Total cash costs fell 10% QoQ. Power generation rose, and net debt was $1.1 billion with liquidity of $840 million. BKV also raised 2026 strategic power capital guidance to $400-$475 million.

$MNRMed

MACH NATURAL RESOURCES LP (MNR): Results of Operations and Financial Condition

MACH NATURAL RESOURCES LP (MNR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea030081701ex99-1.htm PRESS RELEASE ISSUED AUGUST 6, 2026 Exhibit 99.1 Mach Natural Resources LP Reports Second Quarter 2026 Results; Declares Quarterly Cash Distribution of $0. 36 Per Common Unit; Provides Updated 2026 Outlook OKLAHOMA CITY, Oklahoma, August 6, 2026 —

$BKVMed

BKV (NYSE:BKV) Beats Expectations in Strong Q2 CY2026

BKV, a natural gas producer, reported Q2 CY2026 results. Revenue rose 44.6% year on year to $465.5 million, beating Wall Street estimates by 27.4%, and GAAP profit was $0.67 per share above consensus. Adjusted EBITDA margin was 39.1%, and free cash flow was $22.9 million (4.9% margin). Shares rose about 3% to $23.69 after the report.

$BKVMed

BKV Corp (BKV): Results of Operations and Financial Condition

BKV Corp (BKV) filed an SEC Form 8-K — Results of Operations and Financial Condition. 8-K 1 a2q26pressrelease.htm 8-K Document Exhibit 99.1 BKV Corporation Reports Second Quarter 2026 Financial and Operational Results and Updated 2026 Guidance DENVER, Colorado – August 6, 2026 – BKV Corporation (“BKV” or the “Company”) (NYSE: BKV), today reported financial and ope

$OFIXMed

These 7 Small Caps Are On Fire In July: Here's Why - ExxonMobil Holdings (NYSE:XOM), Vertex Pharmaceutica

The Russell 2000 stayed near 3,000 with little movement, while seven small-cap stocks gained at least 28% in four sessions. The article cites July surges for Orthofix (OFIX) on CMS reimbursement reversal, REGENXBIO (RGNX) on FDA resubmission alignment and AbbVie milestone, Verastem (VSTM) on short-squeeze setup, ADC Therapeutics (ADCT) rebound, Sable Offshore (SOC) refinancing, Rapid7 (RPD) takeover speculation, and Crinetics (CRNX) surge toward an offer price.